M 40401

Drug Profile

M 40401

Alternative Names: M40401

Latest Information Update: 27 May 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MetaPhore Pharmaceuticals
  • Class Anti-inflammatories; Anti-ischaemics; Small molecules
  • Mechanism of Action Oxygen radical scavengers; Superoxide dismutase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued HIV infections; Neurological disorders; Reperfusion injury

Most Recent Events

  • 02 Apr 2008 ActivBiotics sells its intellectual property assets including drug product candidates
  • 18 Dec 2007 Suspended - Preclinical for HIV infections treatment in USA (unspecified route)
  • 18 Dec 2007 Suspended - Preclinical for Neurological disorders in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top